Suppr超能文献

超氧化物歧化酶1通过miR-409-3p/超氧化物歧化酶1/SET结构域蛋白1表观遗传调控前馈环促进非小细胞肺癌的细胞增殖和转移。

SOD1 Promotes Cell Proliferation and Metastasis in Non-small Cell Lung Cancer via an miR-409-3p/SOD1/SETDB1 Epigenetic Regulatory Feedforward Loop.

作者信息

Liu Shilong, Li Bin, Xu Jianyu, Hu Songliu, Zhan Ning, Wang Hong, Gao Chunzi, Li Jian, Xu Xiangying

机构信息

Department of Thoracic Radiation Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Plastic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China.

出版信息

Front Cell Dev Biol. 2020 Apr 23;8:213. doi: 10.3389/fcell.2020.00213. eCollection 2020.

Abstract

Superoxide dismutase 1(SOD1) is a major antioxidant with oncogenic effects in many human cancers. Although SOD1 is overexpressed in various cancers, the clinical significance and functions of SOD1 in non-small cell lung cancer (NSCLC), particularly the epigenetic regulation of SOD1 in NSCLC carcinogenesis and progression have been less well investigated. In this study, we found that SOD1 expression was upregulated in NSCLC cell lines and tissues. Further, elevated SOD1 expression could promote NSCLC cell proliferation, invasion and migration. While inhibition of SOD1 expression induced NSCLC G1-phase cell cycle arrest and promoted apoptosis. In addition, miR-409-3p could repress SOD1 expression and significantly counteract its oncogenic activities. Bioinformatics analysis indicated that SET domain bifurcated histone lysine methyltransferase1 (SETDB1) was involved in the epigenetic regulation of miR-409-3p and SOD1 expression and functions in NSCLC cells. Identification of this miR-409-3p/SOD1/SETDB1 epigenetic regulatory feedforward loop may provide new insights into further understanding of NSCLC tumorigenesis and progression. Additionally, our results incicate that SOD1 may be a potential new therapeutic target for NSCLC treatment.

摘要

超氧化物歧化酶1(SOD1)是一种主要的抗氧化剂,在许多人类癌症中具有致癌作用。尽管SOD1在多种癌症中过表达,但SOD1在非小细胞肺癌(NSCLC)中的临床意义和功能,特别是其在NSCLC发生发展过程中的表观遗传调控,尚未得到充分研究。在本研究中,我们发现SOD1在NSCLC细胞系和组织中表达上调。此外,SOD1表达升高可促进NSCLC细胞增殖、侵袭和迁移。而抑制SOD1表达可诱导NSCLC细胞G1期细胞周期阻滞并促进细胞凋亡。此外,miR-409-3p可抑制SOD1表达并显著抵消其致癌活性。生物信息学分析表明,SET结构域双叉组蛋白赖氨酸甲基转移酶1(SETDB1)参与了NSCLC细胞中miR-409-3p和SOD1表达及功能的表观遗传调控。鉴定这种miR-409-3p/SOD1/SETDB1表观遗传调控前馈环可能为进一步理解NSCLC的肿瘤发生和发展提供新的见解。此外,我们的结果表明,SOD1可能是NSCLC治疗的一个潜在新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9257/7190798/961dc4a82939/fcell-08-00213-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验